Hao Zhou

Dr. Hao Zhou


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2018 in Leukemia
Verified
Journal Article
Closed access
PDF file
DPDanyue Peng
Danyue Peng
HWHuifang Wang
Huifang Wang
LLLei Li
Lei Li
XMXiao Ma
Xiao Ma
YCYing Chen
Ying Chen
LLLingbo Liu
Lingbo Liu

26 May 2020 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
WCWanxin Chen
Wanxin Chen
ZLZiping Li
Ziping Li
BYBohan Yang
Bohan Yang
PWPing Wang
Ping Wang
QZQiong Zhou
Qiong Zhou
HZHao Zhou
Hao Zhou

22 May 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
XZXi Zhou
Xi Zhou
HPHuaxiong Pan
Huaxiong Pan
PYPeng Yang
Peng Yang
PYPian Ye
Pian Ye
HCHaiyan Cao
Haiyan Cao
HZHao Zhou
Hao Zhou
Previous studies examining the relationship between hepatitis B virus (HBV) infection and non-Hodgkin lymphoma (NHL) show inconsistent results in different endemic areas. Furthermore, studies evaluating the association between stratified HBV status and NHL with a well-matched case-control design are rare. We conducted a 1:2 case-control study enrolling 3502 NHL cases and 7004 controls, and performed an updated meta-analysis evaluating the association between HBV and NHL subtypes. The HBsAg-negative/anti-HBc-positive/anti-HBs-positive population, implying naturally acquired immunity after infection, had increased B-NHL risk (Adjusted odds ratio (AOR) (95% confidence interval (95% CI)): 2.25 (1.96–2.57)). The HBsAg-positive/HBeAg-positive population, indicating current HBV infection, had high risk of B-NHL (AOR (95% CI): 6.23 (3.95–9.82)). Specifically, for diffuse large B-cell lymphoma (DLBCL), there was no significant difference in HBsAg status between the germinal centre B (GCB) and non-GCB subtypes. Additionally, our meta-analysis showed in a random effects model, HBV-infected individuals had a pooled OR of 2.09 (95% CI 1.76–2.50; P < 0.01) for NHL. Chronic HBV infection was positively associated with B-NHL in China. However, acquired immunity by natural infection also increased B-NHL risk. Thus, we further speculated that regardless of whether HBsAg was cleared, the infected population had higher risk of B-NHL. Our study might expand our knowledge on tumorogenesis of NHL and thus provides clues for novel treatment strategies.

9 November 2021 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
HZHao Zhou
Hao Zhou
WLWei Liu
Wei Liu
YZYongming Zhou
Yongming Zhou
ZHZhenya Hong
Zhenya Hong
JNJian Ni
Jian Ni
JZJianhua Zhu
Jianhua Zhu
Background: Acute myeloid leukemia (AML) is the most common type of leukemia in adults. Its therapy has not significantly improved during the past four decades despite intense research efforts. New molecularly targeted therapies are in great need. The proto-oncogene c-Myc (MYC) is an attractive target due to its transactivation role in multiple signaling cascades. Deregulation of the MYC is considered one of a series of oncogenic events required for tumorigenesis. However, limited knowledge is available on which mechanism underlie MYC dysregulation and how long non-coding RNAs (lncRNAs) are involved in MYC dysregulation in AML. Methods: AML microarray chips and public datasets were screened to identify novel lncRNA GAS6-AS1 was dysregulated in AML. Gain or loss of functional leukemia cell models were produced, and in vitro and in vivo experiments were applied to demonstrate its leukemogenic phenotypes. Interactive network analyses were performed to define intrinsic mechanism. Results: We identified GAS6-AS1 was overexpressed in AML, and its aberrant function lead to more aggressive leukemia phenotypes and poorer survival outcomes. We revealed that GAS6-AS1 directly binds Y-box binding protein 1 (YBX1) to facilitate its interaction with MYC, leading to MYC transactivation and upregulation of IL1R1, RAB27B and other MYC target genes associated with leukemia progression. Further, lentiviral-based GAS6-AS1 silencing inhibited leukemia progression in vivo. Conclusions: Our findings revealed a previously unappreciated role of GAS6-AS1 as an oncogenic lncRNA in AML progression and prognostic prediction. Importantly, we demonstrated that therapeutic targeting of the GAS6-AS1/YBX1/MYC axis inhibits AML cellular propagation and disease progression. Our insight in lncRNA associated MYC-driven leukemogenesis may contribute to develop new anti-leukemia treatment strategies.

26 September 2023 in Cancer Letters
Verified
Journal Article
Closed access
JWJin Wen
Jin Wen
YCYing Chen
Ying Chen
CLChenxi Liao
Chenxi Liao
XMXiao Ma
Xiao Ma
MWMengyuan Wang
Mengyuan Wang
DPDanyue Peng
Danyue Peng

3 May 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
HSHaiping Song
Haiping Song
LCLijuan Chen
Lijuan Chen
WLWei Liu
Wei Liu
XXXiaoli Xu
Xiaoli Xu
YZYongming Zhou
Yongming Zhou
HZHao Zhou
Hao Zhou
Long noncoding RNAs (lncRNAs) are known to play a key role in chronic myelocytic leukemia (CML) development, and we aimed to identify the involvement of the lncRNA HOX antisense intergenic RNA (HOTAIR) in CML via binding to DNA methyltransferase 1 (DNMT1) to accelerate methylation of the phosphatase and tensin homolog (PTEN) gene promoter. Bone marrow samples from CML patients and normal bone marrow samples from healthy controls were collected. HOTAIR, DNMT1, DNMT3A, DNMT3B, and PTEN expression was detected. The biological characteristics of CML cells were detected. The relationship among HOTAIR, DNMT1, and PTEN was verified. Tumor volume and weight in mice injected with CML cells were tested. We found that HOTAIR and DNMT1 expression was increased and PTEN expression was decreased in CML. We also investigated whether downregulated HOTAIR or DNMT1 reduced proliferation, colony formation, invasion, and migration and increased the apoptosis rate of CML cells. Moreover, we tested whether low expression of HOTAIR or DNMT1 reduced the volume and weight of tumors in mice with CML. Collectively, the results of this studied showed that depleted HOTAIR demonstrated reduced binding to DNMT1 to suppress CML progression, which may be related to methylation of the PTEN promoter.